PDCD1 and neoplasm: Compared with the IgG isotype control, tumor growth, volume and weight of subcutaneous Hepa 1-6 tumors were significant reduced by anti-PD-1 antibody, however this effect was largely abolished by midkine overexpression (Fig. 6A–C).